Open access · US-GOV
via ClinicalTrials.gov Clinical trial
The Dutch Multicentre Study Into Opportunistically Screening Geriatric Patients for Atrial Fibrillation Using a PPG Smartphone App; the Dutch-GERAF Study
Authors not listed
Dijklander Ziekenhuis · 2021
Abstract
Geriatric patients are at high risk of cardiovascular complications, and for the development of atrial fibrillation. Often atrial fibrillation exists in these patients without specific symptoms, and could therefore remain unknown. Furthermore, concerns exist about the bleeding profile of anticoagulation in the very elderly or frail patients.
This study applies opportunistic screening for atrial fibrillation as advised in the latest ESC Guideline on the diagnosis and management of atrial fibrillation. Furthermore, multiple bleeding risk scores will be applies, to better assess the bleeding risk in very elderly or frail patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-03 MST
Cite this
APA
Anonymous. (2021). The Dutch Multicentre Study Into Opportunistically Screening Geriatric Patients for Atrial Fibrillation Using a PPG Smartphone App; the Dutch-GERAF Study. <em>Dijklander Ziekenhuis</em>. https://clinicaltrials.gov/study/NCT05337202
Vancouver
Anonymous. The Dutch Multicentre Study Into Opportunistically Screening Geriatric Patients for Atrial Fibrillation Using a PPG Smartphone App; the Dutch-GERAF Study. Dijklander Ziekenhuis. 2021.
BibTeX
@misc{anon2021TheDut,
title = {The Dutch Multicentre Study Into Opportunistically Screening Geriatric Patients for Atrial Fibrillation Using a PPG Smartphone App; the Dutch-GERAF Study},
author = {Anonymous},
journal = {Dijklander Ziekenhuis},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Reviews Disease Primers 2022
Open access · CC-BY
Atrial fibrillation
Allergan 2011
Open access · US-GOV
Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion
Sapere Bio 2015
Open access · US-GOV
The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery
Movement Disorders 2021
Open access · CC-BY
Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia
Ju Qiu 2023
Open access · US-GOV
Comparison of Frailty Screening Performance and Predictive Validity of Adverse Health Outcomes in Breast Cancer Patients Using Frailty Screening Tools
Veterans Medical Research Foundation 2005
Open access · US-GOV